1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. ARS PHARMACEUTICALS INC
ARS Pharmaceuticals Inc
XNAS: SPRY
9.07 0.32 (3.66%)
816.8K
XNAS Volume

XNAS 04 Jun, 2026 4:09 PM (EDT)

Watchlist

Portfolio

Alert

ARS Pharma Inc - SPRY - stock price prediction, stock price target, analyst ratings from 5 analysts

ARS Pharma Inc has a share price target of US$ 29, revenue growth forecast of 77.2%, and profit growth estimate of -4.7% for FY26, based on top 5 analyst calls.